XLVIvsETF 2ETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.49%
VS
Choose a second ETF to run a side-by-side ETF comparison with XLVI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI ETF 2 | -3.75%– | +3.97%– | +5.69%– | +16.54%– | n/a– | n/a– |
| Flows | XLVI ETF 2 | +$4M– | +$11M– | +$14M– | +$25M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI ETF 2 | +11.87%– | +11.09%– | n/a– | n/a– |
| Max drawdown | XLVI ETF 2 | -4.77%– | -8.21%– | n/a– | n/a– |
| Max drawdown duration | XLVI ETF 2 | 16d– | 115d– | n/a– | n/a– |
Trading data
XLVI | ETF 2 | |
Last sale 9/11/2026 at 1:30 PM | $25.71 | – |
| Previous close 09/10/2026 | $25.73 | – |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI | ETF 2 | |
|---|---|---|
| Last price | $25.71 | – |
| 1D performance | -0.07% | – |
| AuM | $25.47 M | – |
| E/R | 0.35% | – |
Characteristics
XLVI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | State Street Investment Management | – |
| Benchmark | - | – |
| N° of holdings | 59 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
XLVI
USA
97.34%
Other
2.66%
ETF 2
Sectors
XLVI
Healthcare
97.32%
Other
2.68%
ETF 2
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
71.63%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
